Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Law channel feed
AstraZeneca disputes IRA’s orphan drug provisions in latest legal challenge to the law
Last year
Pharma
FDA+
CA federal judge allows former employee's case against SomaLogic to continue
Last year
Pharma
US Patent and Trademark Office to hear patent challenge over experimental seizure treatment
Last year
Pharma
Alkermes' $194M payment from Janssen gets approval from court
Last year
Pharma
Ex-employees of Ramaswamy's investment company sue, claiming they were misled or pushed to violate securities law
Last year
People
DOJ plans to take mifepristone challenge to the Supreme Court
Last year
Pharma
FDA+
Federal appeals court restricts access to abortion pill, attempting to revert back to FDA's 2016 restrictions on the drug
Last year
FDA+
One year later: The upsides and downsides of the Inflation Reduction Act
Last year
Teva trial over alleged Medicare kickbacks stopped while pending appeal of potential $10B judgment
Last year
Pharma
Judge strikes down J&J talc unit's second bankruptcy attempt over lack of 'financial distress'
Last year
Pharma
Supreme Court takes on Purdue Pharma bankruptcy case
Last year
Pharma
Gilead agrees to pay $247M to settle HIV drug case that alleged competition blocking
Last year
Pharma
PhRMA urges court to stop government drug price negotiations before they start
Last year
Henrietta Lacks' family sues Ultragenyx over use of immortal HeLa cell line, claiming unjust enrichment
Last year
R&D
Endo sues Zydus in patent battle over methods of purifying generic version of recalled smoking cessation drug Chantix
Last year
Pharma
Drug price increases layered over decades: AARP analysis shows how list prices can rise by more than 700%
Last year
Pharma
AstraZeneca, PhRMA sue Louisiana in federal court over state 340B drug access law
Last year
Pharma
Texas attorney general announces $42.7M settlement with Takeda, Baxter over ADHD drug
Last year
Pharma
Nektar sues Lilly, claiming its interest in biotech’s autoimmune drug ‘waned dramatically’ after buying Dermira
Last year
Pharma
Teva agrees ‘in principle’ to $175M opioid settlement to hospitals and health systems
Last year
Pharma
Corrected: Kentucky takes PBMs to court over 'outrageous' insulin prices
Last year
Pharma
GSK, Pfizer head into patent duel in high-stakes RSV vaccine war
Last year
Pharma
Illumina and Guardant agree to dismiss litigation, share specimen samples after year-long legal battle
Last year
Bristol Myers, AstraZeneca strike $510M settlement on PD-L1, CTLA-4 patent lawsuits
Last year
Pharma
First page
Previous page
16
17
18
19
20
21
22
Next page
Last page